Hangzhou Cancer Hospital
Hangzhou Cancer Hospital
Hangzhou, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PRL3-Zumab in Patients With Advanced Solid Tumors | Advanced Malignant Solid Tumor | Active, not recruiting | Phase 2 | 2026-04-23 | NCT07541001 |